Diversa, another company active in natural product discovery, recognizes the need to add value, but CEO Jay Short believes that biotech companies that take compounds into the clinic are taking a ...

To recognize outstanding efforts in discovery chemistry that demonstrate compelling environmental, safety and/or efficiency improvements through green chemistry and engineering. The ACS Green ...

Biotechnology and drug discovery are fields marked by constant innovation ... Indeed, there is an increasing number of public datasets being generated (i.e., image datasets from compound screens ...

Bakeries and wineries can't do without yeast, but they have no need for green algae. Wastewater treatment facilities, however ...

This fund holds a portfolio of 75-125 biotechnology stocks, balanced between established large-cap names and smaller companies with more growth potential but also more risk. The managers aim to ...

More needs to be done to tap the potential of drug discovery programs in mid-tier biotech companies for innovative ... ranging from improved public image and workforce motivation to a potential ...

A new clinical trial of a ground-breaking phage-based molecular diagnostic, has been agreed. The trial is aimed at evaluating the performance of the phage assay as a first-line blood-based diagnostic ...

Amgen has agreed to buy Swedish biotech Nuevolution for around $167 ... It has its own patent-protected DNA-encoded library drug discovery technology, which enables the efficient discovery of ...

XtalPi, an AI drug discovery company and subsidiary of Ailux Biologics, has entered a licensing agreement with Janssen ...

This fund holds a portfolio of 75-125 biotechnology stocks, balanced between established large-cap names and smaller companies with more growth potential but also more risk. The managers aim to ...